This is an important piece of work that sheds light on our understanding of early lung development. There is solid evidence that there is a key new role for Svep1, which may be acting via FGF9. A more ...

Low climate-impact corticosteroid inhalers are as effective as high climate impact inhalers for COPD and asthma outcomes, per ...

Respiratory medicine is one frontier of the global healthcare landscape which has undergone significant transformations in ...

A rapid decline in lung function is linked to the development of chronic obstructive pulmonary disease (COPD) ...

The label expansion provides a new option for the hundreds of thousands of Americans with inadequately controlled COPD.

Distinct patterns of symptom severity among patients with COPD sheds light on the heterogeneous nature of the patients’ ...

For people in the MetroWest region living with lung diseases such as chronic obstructive pulmonary disease (COPD), emphysema, ...

Sanofi SNY and partner Regeneron REGN announced that the FDA has approved their blockbuster drug, Dupixent, for its sixth ...

Dupixent may help some people with inadequately controlled COPD who have a type of lung inflammation that worsens symptoms.

Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses the impact of changes in lung function in patients with idiopathic pulmonary fibrosis (IPF).

In a study published in the journal Frontiers in Immunology, researchers at the University of Arizona Health Sciences Center ...

COPD, which is the fourth leading cause of death globally ... the drug significantly reduced the moderate or severe ...